Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial ; volume:11 ; number:1 ; day:15 ; month:2 ; year:2011 ; pages:1-7 ; date:12.2011
BMC cancer ; 11, Heft 1 (15.2.2011), 1-7, 12.2011

Creator: Blesius, Aurore

Contributor: Cassier, Philippe A.
Bertucci, François
Fayette, Jerome
Ray-Coquard, Isabelle
Bui, Binh
Adenis, Antoine
Rios, Maria
Cupissol, Didier
Pérol, David
Blay, Jean-Yves
Le Cesne, Axel
SpringerLink (Online service)

DOI: 10.1186/1471-2407-11-72

URN: urn:nbn:de:1111-2016030363612

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Blesius, Aurore
Cassier, Philippe A.
Bertucci, François
Fayette, Jerome
Ray-Coquard, Isabelle
Bui, Binh
Adenis, Antoine
Rios, Maria
Cupissol, Didier
Pérol, David
Blay, Jean-Yves
Le Cesne, Axel
SpringerLink (Online service)

Other Objects (12)

Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST

Reintroduction of Imatinib in GIST

Gastrointestinale Stromatumoren (GIST) : Imatinib-Therapieoptionen voll ausschöpfen durch Dosisoptimierung

Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysis

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)

Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data

Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib

Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib

Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib

Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)

Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib

The management of metastatic GIST: current standard and investigational therapeutics

Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST

Reintroduction of Imatinib in GIST

Gastrointestinale Stromatumoren (GIST) : Imatinib-Therapieoptionen voll ausschöpfen durch Dosisoptimierung

Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysis

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)

Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data

Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib

Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib

Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib

Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)

Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib

The management of metastatic GIST: current standard and investigational therapeutics

Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST

Reintroduction of Imatinib in GIST

Gastrointestinale Stromatumoren (GIST) : Imatinib-Therapieoptionen voll ausschöpfen durch Dosisoptimierung

Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysis

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)

Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data

Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib

Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib

Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib

Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)

Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib

The management of metastatic GIST: current standard and investigational therapeutics

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST

Reintroduction of Imatinib in GIST

Gastrointestinale Stromatumoren (GIST) : Imatinib-Therapieoptionen voll ausschöpfen durch Dosisoptimierung

Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysis

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)

Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data

Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib

Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib

Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib

Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)

Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib

The management of metastatic GIST: current standard and investigational therapeutics

Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST

Reintroduction of Imatinib in GIST

Gastrointestinale Stromatumoren (GIST) : Imatinib-Therapieoptionen voll ausschöpfen durch Dosisoptimierung

Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysis

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)

Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data

Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib

Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib

Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib

Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)

Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib

The management of metastatic GIST: current standard and investigational therapeutics

Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST

Reintroduction of Imatinib in GIST

Gastrointestinale Stromatumoren (GIST) : Imatinib-Therapieoptionen voll ausschöpfen durch Dosisoptimierung

Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysis

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)

Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data

Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib

Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib

Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib

Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)

Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib

The management of metastatic GIST: current standard and investigational therapeutics

Related objects

Reset password